PDL BioPharma, Inc. Lease, Cost
PDL BioPharma, Inc. reported Lease, Cost of $581.00 thousand for the 8-month period ending 2020-08-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2021-03-29
- PDL BioPharma, Inc. lease, cost for the quarter ending 2019-12-31 was $41.00K, a 62.39% decline year-over-year.
- PDL BioPharma, Inc. lease, cost for the quarter ending 2019-09-30 was $287.00K, a 4.97% decline year-over-year.
- PDL BioPharma, Inc. lease, cost for the quarter ending 2019-06-30 was $253.00K, a 24.70% decline year-over-year.
- PDL BioPharma, Inc. lease, cost for the quarter ending 2019-03-31 was $258.00K, a 13.13% decline year-over-year.
- PDL BioPharma, Inc. lease, cost for fiscal 2019 was $839.00K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 8 month | Lease, Cost 9 month | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-08-31 | $581.00K 10-K · filed 2021-03-29 | |||||
| 2019-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $328.00K derived: sum of 2 quarters · filed 2021-03-29 | $581.00K derived: sum of 3 quarters · filed 2021-03-29 | $839.00K 10-K · filed 2021-03-29 | $1.00M 10-K · filed 2020-03-11 | |
| 2019-09-30 | $287.00K 10-Q · filed 2019-11-06 | $540.00K derived: sum of 2 quarters · filed 2019-11-06 | $798.00K 10-Q · filed 2019-11-06 | $907.00K derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2019-06-30 | $253.00K 10-Q · filed 2019-08-07 | $511.00K 10-Q · filed 2019-08-07 | $620.00K derived: sum of 3 quarters · filed 2020-06-29 | $922.00K derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2019-03-31 | $258.00K 10-Q · filed 2019-05-09 | $367.00K derived: sum of 2 quarters · filed 2020-06-29 | $669.00K derived: sum of 3 quarters · filed 2020-06-29 | $1.00M derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2018-12-31 | $109.00K derived: 8-K 12 month − 10-Q 9 month · filed 2020-06-29 | $411.00K derived: sum of 2 quarters · filed 2020-06-29 | $747.00K derived: sum of 3 quarters · filed 2020-06-29 | $1.04M 8-K · filed 2020-06-29 | $1.24M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $302.00K 10-Q · filed 2019-11-06 | $638.00K derived: sum of 2 quarters · filed 2019-11-06 | $935.00K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $336.00K 10-Q · filed 2019-08-07 | $633.00K 10-Q · filed 2019-08-07 | ||||
| 2018-03-31 | $297.00K 10-Q · filed 2019-05-09 |